N/A
N=11
Familial Hyperlipidemia Family Registry
Familial Hyperlipidemia
Bottom Line
View on ClinicalTrials.gov: NCT05814419 ↗Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcome: Primary: Familial Hypercholesterolemia (FH) Determination for Family Members of School Children With Elevated Cholesterol and Documented FH Variant — 3; 8 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult · 0+ yrs
- Sex
- All
- Sponsor
- Poudre Valley Health System
- Primary completion
- May 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Familial Hypercholesterolemia (FH) Determination for Family Members of School Children With Elevated Cholesterol and Documented FH Variant |
3; 8 | — |
Summary
If a child from the Healthy Hearts and Minds education and screening program is found to have a genetic marker for familial hyperlipidemia (FH), immediate family members are offered genetic testing at no charge to identify those at high risk for cardiovascular disorders and those who carry the genetic markers. If identified early, the risk for cardiovascular disease can be greatly modified by early and proper treatment.
The aim of the study is to gauge the impact of large-scale surveillance testing to identify those with the disorder and improve clinical care. This impact is both in disease prevention and in lessening the cost of long-term care from premature cardiovascular disease.
Eligibility Criteria
Inclusion Criteria
- Primary family member of child from school screening program with documented familial hyperlipidemia (FH) variant
Exclusion Criteria
- none
Data sourced from ClinicalTrials.gov (NCT05814419). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.